Treasury Chief Reeves Plans Focused Measures on Living Costs in Forthcoming Budget

Chancellor Rachel Reeves has stated she is planning "specific measures to deal with cost of living issues" in the forthcoming Budget.

In comments to media outlets, she noted that reducing inflation is a joint duty of both the government and the Bank of England.

The United Kingdom's price growth is forecast to be the highest among the Group of Seven advanced economies this calendar year and next.

Possible Utility Cost Measures

It is understood the administration could intervene to reduce utility costs, for example by cutting the current 5% rate of value-added tax applied on energy supplies.

An additional possibility is to lower some of the government charges currently added to household expenses.

Budgetary Limitations and Analyst Expectations

The administration will receive the latest report from the independent fiscal watchdog, the OBR, on the start of the week, which will clarify how much scope there is for such actions.

The expectation from the majority of analysts is that Reeves will have to declare tax rises or expenditure reductions in order to adhere to her self-imposed borrowing rules.

Previously on Thursday, calculations showed there was a twenty-two billion pound deficit for the chancellor to resolve, which is at the more modest range of projections.

"There's a shared responsibility between the Bank of England and the administration to continue tackling some of the sources of price increases," Reeves stated to reporters in the US capital, at the annual meetings of the International Monetary Fund and World Bank.

Tax Pledges and Global Issues

While much of the attention has been on probable tax rises, the chancellor said the latest figures from the fiscal watchdog had not altered her vow to election pledges not to increase tax levels on income tax, sales tax or National Insurance.

She blamed an "uncertain global environment" with rising international and trade tensions for the Budget revenue measures, likely to be directed on those "most able to pay."

Global Economic Tensions

Referring to worries about the UK's trade ties with China she said: "The UK's national security invariably are paramount."

Recent announcement by Chinese authorities to tighten trade restrictions on rare earths and other materials that are crucial for advanced tech production led American leader Donald Trump to threaten an additional 100% import tax on imports from China, raising the risk of an full-scale commercial conflict between the two economic giants.

The American finance chief labeled China's action "commercial pressure" and "a international production control attempt."

Asked about considering the US offer to participate in its dispute with the Asian nation, the Chancellor said she was "very concerned" by China's measures and urged the Beijing authorities "to avoid restrictions and limit trade."

She said the decision was "damaging for the international commerce and creates further headwinds."

"In my view there are areas where we must challenge Chinese policies, but there are also important prospects to export to Chinese markets, including financial services and other areas of the economy. We've got to maintain that equilibrium appropriate."

The Treasury chief also stated she was collaborating with other major economies "on our own essential resources approach, so that we are reduced dependence."

NHS Drug Costs and Investment

Reeves also recognized that the price the NHS pays for pharmaceuticals could increase as a consequence of ongoing negotiations with the Trump administration and its drugs companies, in return for reduced taxes and funding.

A number of the world's largest pharmaceutical manufacturers have said recently that they are either delaying or scrapping investments in the United Kingdom, with several attributing the insufficient payments they are getting.

Recently, the Science Minister said the price the NHS spends on medicines would have to increase to stop businesses and drug research funding leaving the UK.

The Chancellor informed the BBC: "It has been observed due to the pricing regime, that clinical trials, new drugs have not been available in the UK in the manner that they are in other European countries."

"Our aim is to make sure that people receiving care from the National Health Service are can receive the top life-saving medicines in the globe. And so we are examining these issues, and... seeking to attract more investment into Britain."